Table 5.
Follow-up of 7 patients with AML-M2/M3 until 30th june, 2012
| Chemotherapy treatment | Subsequent | Time*(days, d) | Final diagnosis | |
|---|---|---|---|---|
| In our deparmett | Treatment | |||
| Case 1 | 3 cycles | allo-SCT** | 1630d | CR |
| Case 2 | 4 cycles | auto-SCT | 1492d | CR |
| Case 3 | 1 cycle | - | 3d | Death |
| Case 4 | 5 cycles | allo-SCT | 766d | CR |
| Case 5 | 1 cycle | - | >29d | Non-remission, lost at follow-up |
| Case 6 | 4 cycles | - | 467d | Recurrence, transformed into AMLM2 |
| Case 7 | 1 cycle | - | 53d | CR |
allo-SCT, allogeneic stem cell transplantation; auto-SCT: autologous stem cell transplantation.
*closing date: 30 June, 2012.
**the patient had the allo-SCT in another hospital.